Our proven executive team brings deep, diverse cell therapy and oncology experience and is committed to developing safe, effective, and accessible NK cell therapies for cancer. Artiva's Board of Directors and Advisors bring years of expertise to help us realize the full potential of NK cell therapies.

Tom Farrell

Founding President & CEO

Esther van den Boom, CPA

Chief Financial Officer

John Lim, Pharm.D.

Vice President, Clinical Operations

Peter Flynn, Ph.D.

Chief Operating Officer

Anne Frese

Vice President, Human Resources

Sungyong Won, Ph.D.

Vice President, Alliance Management

Jason Litten, M.D.

Chief Medical Officer

Eugene Helsel

Vice President, Regulatory Affairs & Quality

 

Sign up for news updates

  • Twitter
  • LinkedIn

Privacy Policy  |  Terms
© Artiva Biotherapeutics, Inc., 2020